Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-034965
Filing Date
2024-11-13
Accepted
2024-11-13 17:15:14
Documents
62
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q acrx20240930_10q.htm   iXBRL 10-Q 1450915
2 EXHIBIT 31.1 ex_742984.htm EX-31.1 8102
3 EXHIBIT 31.2 ex_742985.htm EX-31.2 8108
4 EXHIBIT 32.1 ex_742986.htm EX-32.1 5947
  Complete submission text file 0001437749-24-034965.txt   6260383

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA tlph-20240930.xsd EX-101.SCH 55496
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tlph-20240930_def.xml EX-101.DEF 387962
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlph-20240930_lab.xml EX-101.LAB 331417
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlph-20240930_pre.xml EX-101.PRE 410141
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tlph-20240930_cal.xml EX-101.CAL 36107
65 EXTRACTED XBRL INSTANCE DOCUMENT acrx20240930_10q_htm.xml XML 944241
Mailing Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404
Business Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404 650-216-3500
TALPHERA, INC. (Filer) CIK: 0001427925 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35068 | Film No.: 241455649
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)